From 2008 to 2022, rates for precancerous lesions decreased about 80 percent among 20- to 24-year-old women who were screened ...
A first-of-its-kind antiviral gel may offer the potential to stop papillomavirus (HPV) infection before it causes cancer. ( ...
Genital HPV infections are thought to be responsible for more than 99% of cervical cancers. At least partly because the ...
A team from University Hospitals Seidman Cancer Center is launching the nation's first-ever clinical trials evaluating the ...
The human papillomavirus (HPV) vaccine is having a huge impact on cervical cancer prevention among young women, a U.S.
Why it matters: The CDC report shows that rates of precancerous lesions among women aged 20-24 screened for cervical cancer ...
The study shows an almost 80% drop in rates of cervical precancers among women ages 20-24 from 2008 to 2022, correlating to vaccine uptake. Simultaneously, an mRNA pancreatic cancer vaccine is showing ...